25 results
Thumbnail

D1.496 - Variation in platelet-activating factor levels among patients with chronic spontaneous urticaria

Thumbnail

D1.507 - Biomarkers of T2-airway inflammation in patients with asthma and COPD overlap

Thumbnail

D1.498 - Altered B Cell Dynamics in Childhood-Onset Systemic Lupus Erythematosus: Insights from Disease States and Rituximab Treatment

Thumbnail

D1.504 - Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with SARS-CoV-2: Clinical Characteristics and Outcomes in a series of pediatric cases

Thumbnail

D1.506 - Mast cell activation and type 2 inflammation in heart failure with preserved ejection fraction: a pilot cross-sectional study

Thumbnail

D1.508 - Assessment of automated serum sIgG testing for key bacterial pathogens in Cystic Fibrosis

Thumbnail

D1.510 - Fecal Calprotectin as a Marker for Differentiating Children with Atopic Dermatitis With and Without Food Allergy

Thumbnail

D1.511 - Hereditary alpha-tryptasemia in chronic spontaneous urticaria: prevalence and clinical impact

Thumbnail

D1.513 - Reduced Expression of PDCD4 on CD14+ Monocytes Correlates with Inflammatory Severity in Neonatal Sepsis: A Pilot Study

Thumbnail

D2.449 - Patients with Inadequately Controlled CRSwNP and Blood Eosinophil Count ≥150 cells/µL Experience Benefit with Depemokimab: An Analysis of Data from the Integrated ANCHOR-1/-2 Studies

Thumbnail

D2.447 - Phenotyping of Chronic T2 Inflammatory Diseases of the Nose and Paranasal Sinuses and the Algorithm for Biologic Therapy Selection

Thumbnail

D2.448 - Recommendations on Patient Education for Biological Therapy in CRSwNP – An EAACI Position Paper

Thumbnail

D2.452 - Real-World Trends in the Epidemiology and Burden of Chronic Rhinosinusitis with Nasal Polyps Over Time in Germany Reveal Increasing Prevalence and Low Biologic Use

Thumbnail

D2.455 - Does Biological Therapy Modify NSAID Hypersensitivity? Experience with Omalizumab and Mepolizumab in Patients with Asthma and Nasal Polyps with N-ERD

Thumbnail

D2.456 - Chronic sinusitis with nasal polyposis: Add-on aspirin desensitization useful in dupilumab therapy?

Thumbnail

D2.461 - Endothelial related miRs are dysregulated in C1-INH Angioedema patients: new potential biomarkers and therapeutic targets

Thumbnail

D2.462 - Safety and predictors of tolerance in rituximab hypersensitivity management

Thumbnail

D2.490 - Consistent efficacy of a seasonal 300IR birch pollen sublingual immunotherapy in children and adolescents during worst pollen exposure: results of the YOBI trial

Thumbnail

D2.491 - Efficacy of a 300IR birch liquid sublingual immunotherapy during the alder and hazel pollen seasons: results of the YOBI trial

Thumbnail

D2.492 - Efficacy and safety of a 300IR daily dose of a SLIT of birch pollen allergen extract in children and adolescents with allergic rhinoconjunctivitis: results from the YOBI trial